SCHEMBL3279995

SCHEMBL3279995

C#C/C=C(\CC)c1cccc(CCc2ccc(CO[Si](C)(C)C(C)(C)C)c(CO[Si](C)(C)C(C)(C)C)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
VDR P11473 5/20 0.41
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3280000 1.00 VDR (0.41) VDRBACE1
SCHEMBL3280003 1.00 VDR (0.41) VDRBACE1
SCHEMBL3280271 0.87 VDR (0.48) VDR
SCHEMBL3283547 0.86 VDR (0.44) VDR
SCHEMBL3280274 0.86 VDR (0.44) VDR
SCHEMBL3283554 0.86 VDR (0.44) VDR
SCHEMBL3279902 0.86 VDR (0.44) VDRBACE1
SCHEMBL3279899 0.86 VDR (0.44) VDRBACE1
SCHEMBL3279894 0.86 VDR (0.44) VDRBACE1
SCHEMBL3278871 0.85 VDR (0.46) VDRBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700657-B2 Vitamin D analogs GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-04-20 US disclosed
EP-1395538-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2009-12-30 EP disclosed
US-20040224929-A1 Novel vitamin D analogs GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-11-11 US disclosed
EP-1395538-A1 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2004-03-10 EP disclosed
WO-2002094754-A1 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2002-11-28 WO disclosed